title: Evolution of plasma specific fibrin degradation products during thrombolytic therapy in patients with thrombo-embolism.
authors.affiliation: Service de cardiologie, hôpital St Jacques, Besancon, France.
authors.forename: R
authors.initials: R
authors.lastname: Faivre
authors.forename: M
authors.initials: M
authors.lastname: Mirshahi
authors.forename: D
authors.initials: D
authors.lastname: Ducellier
authors.forename: C
authors.initials: C
authors.lastname: Soria
authors.forename: J
authors.initials: J
authors.lastname: Soria
authors.forename: M
authors.initials: M
authors.lastname: Mirshahi
authors.forename: Y
authors.initials: Y
authors.lastname: Kieffer
authors.forename: J P
authors.initials: JP
authors.lastname: Bassand
authors.forename: J
authors.initials: J
authors.lastname: Caen
authors.forename: J P
authors.initials: JP
authors.lastname: Maurat
mesh_terms: D000328:Adult; D000368:Aged; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D011655:Pulmonary Embolism / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011859:Radiography; D013300:Streptokinase / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
chemical_list: D005338:Fibrin Fibrinogen Degradation Products; D005343:Fibrinolytic Agents; D006493:Heparin; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator